Adtalem Global Education (NYSE:CVSA) SVP Douglas Beck Sells 2,439 Shares

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 2,439 shares of the business’s stock in a transaction that occurred on Wednesday, July 8th. The shares were sold at an average price of $135.34, for a total transaction of $330,094.26. Following the completion of the transaction, the senior vice president owned 33,070 shares of the company’s stock, valued at $4,475,693.80. The trade was a 6.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Shares of Adtalem Global Education stock traded up $0.32 on Thursday, reaching $131.17. 316,206 shares of the stock were exchanged, compared to its average volume of 371,981. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market cap of $4.46 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.02 and a beta of 0.62. The firm’s 50 day simple moving average is $124.04. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business had revenue of $487.03 million for the quarter. During the same period last year, the business earned $1.92 earnings per share. The business’s revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities research analysts expect that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Truist Financial boosted their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Monday, June 8th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.